A Day Up For MiNK Therapeutics Inc.

Fri, Nov 11, 2022 at 07:56 PM
A Day Up For MiNK Therapeutics Inc.

MiNK Therapeutics Inc. (INKT:NASDAQ) soared at $3, representing a gain of 35.7%. On Fri, Nov 11, 2022, INKT:NASDAQ hit a New 2-Week High of $3. The stock appeared on our News Catalysts scanner on Thu, Nov 10, 2022 at 11:26 AM in the 'BIOTECH' category. From Mon, Oct 31, 2022, the stock recorded 55.56% Up Days and 70.00% Green Days

The stock spiked on Wed, Aug 17, 2022 at $4.32 with a volume of 1M+.

About MiNK Therapeutics Inc. (INKT:NASDAQ)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.